Page 41 - Development Expense News Today : Breaking News, Live Updates & Top Stories | Vimarsana

•Reaffirms 2021 Full Year Forecast for Revenues and Profit GAITHERSBURG, Md., July 29, 2021-Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2021. 'Our second quarter performance demonstrates the strength of our strategy and diversified business model,' said Robert G. Kramer, president and chief executive officer of Emergent BioSolutions. 'Through continued investment and innovation, we will play an important role in helping deliver solutions to the public health threats we face. We are proud to be resuming produ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alkami Announces First Quarter 2021 Financial Results Alkami Technology, Inc.May 11, 2021 GMT PLANO, Texas, May 11, 2021 (GLOBE NEWSWIRE) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions provider for U.S.-based financial institutions, announced today results for its first quarter ending March 31, 2021. First Quarter 2021 Financial Highlights GAAP total revenue of $33.3 million, an increase of 43% year-over-year; GAAP gross margin of 53.4%, an...

Beyond the disastrous first-quarter results, new CEO Bob Lyons has an ambitious long-term goal.

Overview Tennant Company is a world leader in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutio...

Share this article Share this article SAN FRANCISCO, May 4, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the first quarter ended March 31, 2021 signaling continued momentum into 2021. "We had a very strong start to the year, experiencing record daily volumes, and we expect that momentum to continue into the coming years," said Sean George, co-founder and chief executive officer of Invitae. "Genetic information is the foundation for personalized medicine, and we believe Invitae is uniquely positio...